Recent Finacing
Recent Raise
Germany-based pharmaceutical R&D company developing AC102, a locally delivered small-molecule regenerative therapy for inner-ear disorders (acute/chronic hearing loss and tinnitus), advancing through clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at AudioCure Pharma.
